The Pharma Letter has published an expert view by Ramji Vasudevan, Head of Life Sciences at Altimetrik, titled “AI-first is not a strategy. It’s how the next generation of pharmaceuticals will operate.”
In the article, Ramji explains why pharmaceutical companies must move beyond pilots and embrace AI-first operations as a foundation for growth. He highlights Altimetrik’s own journey including the creation of Alti AI Adoption Lab, an AI innovation engine that accelerates experiments across drug discovery, clinical development, manufacturing, supply chain intelligence, and commercial analytics. By reducing time-to-value for AI initiatives by over 30%, Alti AI Adoption Lab demonstrates how pharma can achieve faster, scalable results.
Ramji also stresses that the real shift is cultural, not just technological requiring leadership to integrate AI deeply into core processes while empowering employees to adopt new AI-driven capabilities. With agentic AI on the horizon, he calls on pharma leaders to take decisive action or risk being outpaced by AI-native competitors.
Altimetrik partners with Google Cloud to launch a Gemini Enterprise capability center, enabling production-scale AI agents and accelerating enterprise AI transformation globally.
A landmark HFS Research and Altimetrik study of 505 Global 2000 executives exposes a critical AI governance gap only 14% of enterprises have a clear AI strategy, and most lack defined human accountability when AI makes decisions. Here’s what it means for your organization.
DETROIT — April 8, 2026 — Across enterprises, AI shapes hiring decisions, influences capital allocation, triggers compliance actions, and steers operational trade-offs at a scale no executive team can realistically supervise. A new report from Altimetrik, in partnership with HFS Research, finds that the vast majority of enterprises have deployed AI without answering a fundamental […]
Altimetrik is committed to protecting your personal information. To apply for a position, you will need to provide your email address and create a login. Your information will be used in accordance with applicable data privacy laws, our Privacy Policy, and our Privacy Notice.
